Search Results - Shengyou Lin

Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis by Jingyang Su, Jingyang Su, Jialin Zhang, Yuqian Wu, Cui Ni, Yueyue Ding, Zelin Cai, Ming Xu, Mingyang Lai, Jue Wang, Shengyou Lin, Jinhua Lu

Connect to this object online.